Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294

A letter to the editor is presented which discusses the introduction of imatinib mesylate (IM) in the medical case of an 18-year old man with in-frame mutations and blast transformation of chronic myeloid leukemia (CML).

Saved in:
Bibliographic Details
Main Authors: Nadarajan, V.S., Ang, C.H., Syed-Sultan, M.K., Bee, P.C.
Format: Article
Published: Springer Verlag (Germany) 2012
Subjects:
Online Access:http://eprints.um.edu.my/12027/
http://link.springer.com/article/10.1007%2Fs00277-011-1215-2
http://dx.doi.org/10.1007/s00277-011-1215-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first